NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Brain Research. Molecular Brain Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12399113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NF-kappaB in neuronal plasticity and neurodegenerative disorders.

  2001cited by this paper
• Alpha2 macroglobulin and the risk of Alzheimer's disease.

  2000cited by this paper
• Association of interleukin‐1 gene polymorphisms with Alzheimer's disease

  2000cited by this paper
• Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.

  2000cited by this paper
• Association of early‐onset Alzheimer's disease with an interleukin‐1α gene polymorphism

  2000cited by this paper
• Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.

  1998cited by this paper
• The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation.

  1998cited by this paper
• Signal transduction through NF-kappa B.

  1998cited by this paper
• Alpha-2 macroglobulin is genetically associated with Alzheimer disease

  1998cited by this paper
• Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons.

  1998cited by this paper
• Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease.

  1997cited by this paper
• alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein.

  1997cited by this paper
• Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains.

  1997cited by this paper
• Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF‐κB

  1997cited by this paper
• Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.

  1997cited by this paper
• Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein.

  1997cited by this paper
• Nuclear translocation of NF‐κB in cholinergic neurons of patients with Alzheimer's disease

  1997cited by this paper
• Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B

  1995cited by this paper
• Evidence for the Binding of a Biologically Active Interleukin-2 to Human α2-Macroglobulin (*)

  1995cited by this paper
• Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells.

  1994cited by this paper
• Expression of the alpha 2-macroglobulin-encoding gene in rat brain and cultured astrocytes.

  1994cited by this paper
• alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease.

  1993cited by this paper
• Immunohistochemical study of alpha 2 macroglobulin receptor in Alzheimer and control postmortem human brain.

  1993cited by this paper
• α2“Macroglobulin, a multifunctional binding protein with targeting characteristics

  1992cited by this paper
• Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients.

  1992cited by this paper
• Synthesis and secretion of alpha 2-macroglobulin by human glioma established cell lines.

  1992cited by this paper
• Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

  1991cited by this paper
• The human alpha 2-macroglobulin receptor contains high affinity calcium binding sites important for receptor conformation and ligand recognition.

  1990cited by this paper
• Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin.

  1989cited by this paper
• The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

  1973cited by this paper
• The combining ratio between trypsin and serum alpha-2-macroglobulin.

  1966cited by this paper

• Therapeutic Potential of Cannabinoids—Perspectives for the Future

  2014cites this paper
• Oxidative damage in Alzheimer’s disease

  2014cites this paper
• The contribution of a murine CNS-TB model for the understanding of the host-pathogen interactions in the formation of granulomas.

  2012cites this paper
• Prion peptide-mediated cellular prion protein overexpression and neuronal cell death can be blocked by aspirin treatment.

  2011cites this paper
• Paeonol attenuates H₂O₂-induced NF-κB-associated amyloid precursor protein expression.

  2010cites this paper
• Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide

  2008cites this paper
• Strategic environmental assessment in China: motivations, politics, and effectiveness.

  2008cites this paper
• Novel strategies for Alzheimer's disease treatment

  2007cites this paper
• Endocannabinoids and neurodegenerative diseases.

  2007cites this paper
• Effects of essential oils and aromatherapy on cognitive function in dementia : laboratory studies and application in aged care facility residents

  2006cites this paper
• Interleukins, inflammation, and mechanisms of Alzheimer's disease.

  2006cites this paper
• Inflammatory cytokines and NFκB in Alzheimer’s disease.

  2006cites this paper
• Transcriptional profiling of spinal cord injury‐induced central neuropathic pain

  2005cites this paper
• Decreased proinflammatory cytokine production by peripheral blood mononuclear cells from vitiligo patients following aspirin treatment.

  2005cites this paper
• Expression of acute-phase response proteins in retinal Müller cells in diabetes.

  2005cites this paper
• Identification and characterization of CPAMD8, a novel member of the complement 3/alpha2-macroglobulin family with a C-terminal Kazal domain.

  2004cites this paper
• What are all the things that aspirin does?

  2003cites this paper
• Blood-Brain Barrier Damage Induces Release of α2-Macroglobulin*

  2003cites this paper